Cargando…
Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development
BACKGROUND: Accumulating evidence suggests that the C-C chemokine ligand 2 (CCL2, or monocyte chemoattractant protein 1) acts as a neuromodulator in the central nervous system through its binding to the C-C chemokine receptor 2 (CCR2). Notably, it is well established that the CCL2/CCR2 axis plays a...
Autores principales: | Bégin-Lavallée, Valérie, Midavaine, Élora, Dansereau, Marc-André, Tétreault, Pascal, Longpré, Jean-Michel, Jacobi, Ashley M, Rose, Scott D, Behlke, Mark A, Beaudet, Nicolas, Sarret, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956154/ https://www.ncbi.nlm.nih.gov/pubmed/27306408 http://dx.doi.org/10.1177/1744806916653969 |
Ejemplares similares
-
Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity
por: Dansereau, Marc-André, et al.
Publicado: (2021) -
Single-pot enzymatic synthesis of Dicer-substrate siRNAs
por: Guiley, Keelan Z., et al.
Publicado: (2012) -
Knockdown of β-catenin with Dicer-Substrate siRNAs Reduces Liver Tumor Burden In vivo
por: Dudek, Henryk, et al.
Publicado: (2014) -
A role for human Dicer in pre-RISC loading of siRNAs
por: Sakurai, Kumi, et al.
Publicado: (2011) -
Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA
por: Raja, Maria Abdul Ghafoor, et al.
Publicado: (2019)